Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284

1.

Workload Differentiates Breast Surgical Procedures: NSM Associated with Higher Workload Demand than SSM.

Hallbeck MS, Law KE, Lowndes BR, Linden AR, Morrow M, Blocker RC, Cain SM, Degnim AC, Hieken TJ, Jakub JW, Racz JM, Farley DR, Nelson H, Boughey JC.

Ann Surg Oncol. 2020 Jan 8. doi: 10.1245/s10434-019-08159-0. [Epub ahead of print]

PMID:
31916090
2.

Integrated cancer networks improve compliance with national guidelines and outcomes for resectable gastric cancer.

Thiels CA, Hanson KT, Habermann EB, Boughey JC, Grotz TE.

Cancer. 2019 Dec 10. doi: 10.1002/cncr.32660. [Epub ahead of print]

PMID:
31821545
3.

Infections following Immediate Implant-Based Breast Reconstruction: A Case-Control Study over 11 Years.

Banuelos J, Sabbagh MD, Roh SG, Nguyen MT, Lemaine V, Tran NV, Jacobson SR, Boughey JC, Jakub JW, Hieken TJ, Degnim AC, Mandrekar J, Berbari E, Sharaf B.

Plast Reconstr Surg. 2019 Dec;144(6):1270-1277. doi: 10.1097/PRS.0000000000006202.

PMID:
31764629
4.

Follow-up Care for Breast Cancer Survivors.

Ruddy KJ, Herrin J, Sangaralingham L, Freedman RA, Jemal A, Haddad TC, Allen SV, Hieken T, Boughey JC, Ganz PA, Havyer RD, Shah ND.

J Natl Cancer Inst. 2020 Jan 1;112(1):111-113. doi: 10.1093/jnci/djz203.

PMID:
31613369
5.

Male breast cancer in the United States: Treatment patterns and prognostic factors in the 21st century.

Yadav S, Karam D, Bin Riaz I, Xie H, Durani U, Duma N, Giridhar KV, Hieken TJ, Boughey JC, Mutter RW, Hawse JR, Jimenez RE, Couch FJ, Leon-Ferre RA, Ruddy KJ.

Cancer. 2020 Jan 1;126(1):26-36. doi: 10.1002/cncr.32472. Epub 2019 Oct 7.

PMID:
31588557
6.

Use of a Wearable EEG Headband as a Meditation Device for Women With Newly Diagnosed Breast Cancer: A Randomized Controlled Trial.

Millstine DM, Bhagra A, Jenkins SM, Croghan IT, Stan DL, Boughey JC, Nguyen MT, Pruthi S.

Integr Cancer Ther. 2019 Jan-Dec;18:1534735419878770. doi: 10.1177/1534735419878770.

7.

A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition.

Shee K, Wells JD, Ung M, Hampsch RA, Traphagen NA, Yang W, Liu SC, Zeldenrust MA, Wang L, Kalari KR, Yu J, Boughey JC, Demidenko E, Kettenbach AN, Cheng C, Goetz MP, Miller TW.

Clin Cancer Res. 2020 Jan 1;26(1):159-170. doi: 10.1158/1078-0432.CCR-18-2213. Epub 2019 Sep 26.

PMID:
31558472
8.

ASO Author Reflections: Disease Patterns and Treatment of Adolescents and Young Women with Breast Cancer.

Murphy BL, Boughey JC.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):735-736. doi: 10.1245/s10434-019-07835-5. Epub 2019 Sep 18. No abstract available.

PMID:
31535300
9.

Identifying Residual Nodal Disease in Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Breast Cancer.

Boughey JC.

Ann Surg Oncol. 2019 Nov;26(12):3794-3797. doi: 10.1245/s10434-019-07733-w. Epub 2019 Aug 19. No abstract available.

PMID:
31429022
10.

Two-Staged Implant-Based Breast Reconstruction: A Long-Term Outcome Study in a Young Population.

Manrique OJ, Charafeddine A, Abu-Ghname A, Banuelos J, Jacobson SR, Martinez-Jorge J, Nguyen MD, Harless C, Tran NV, Sharaf B, Jakub JW, Hieken TJ, Degnim AC, Boughey JC.

Medicina (Kaunas). 2019 Aug 14;55(8). pii: E481. doi: 10.3390/medicina55080481.

11.

Adolescents and Young Adults with Breast Cancer have More Aggressive Disease and Treatment Than Patients in Their Forties.

Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC.

Ann Surg Oncol. 2019 Nov;26(12):3920-3930. doi: 10.1245/s10434-019-07653-9. Epub 2019 Aug 2.

PMID:
31376035
12.

Outcomes of > 1300 Nipple-Sparing Mastectomies with Immediate Reconstruction: The Impact of Expanding Indications on Complications.

Young WA, Degnim AC, Hoskin TL, Jakub JW, Nguyen MD, Tran NV, Harless CA, Manrique OJ, Boughey JC, Hieken TJ.

Ann Surg Oncol. 2019 Oct;26(10):3115-3123. doi: 10.1245/s10434-019-07560-z. Epub 2019 Jul 24.

PMID:
31342370
13.

Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.

Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, Boolbol SK, Taylor WA.

Ann Surg Oncol. 2019 Oct;26(10):3025-3031. doi: 10.1245/s10434-019-07549-8. Epub 2019 Jul 24.

14.

Effect of Surgery Type on Time to Adjuvant Chemotherapy and Impact of Delay on Breast Cancer Survival: A National Cancer Database Analysis.

Kupstas AR, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2019 Oct;26(10):3240-3249. doi: 10.1245/s10434-019-07566-7. Epub 2019 Jul 22.

PMID:
31332635
15.

Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.

Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JC.

JAMA Surg. 2019 Jul 17. doi: 10.1001/jamasurg.2019.1742. [Epub ahead of print]

PMID:
31314062
16.

Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall.

Moyer AM, Yu J, Sinnwell JP, Dockter TJ, Suman VJ, Weinshilboum RM, Boughey JC, Goetz MP, Visscher DW, Wang L.

Oncotarget. 2019 Jun 11;10(39):3924-3930. doi: 10.18632/oncotarget.27001. eCollection 2019 Jun 11.

17.

Post-mastectomy intensity modulated proton therapy after immediate breast reconstruction: Initial report of reconstruction outcomes and predictors of complications.

Smith NL, Jethwa KR, Viehman JK, Harmsen WS, Gonuguntla K, Elswick SM, Grauberger JN, Amundson AC, Whitaker TJ, Remmes NB, Harless CA, Boughey JC, Nguyen MT, Park SS, Corbin KS, Mutter RW.

Radiother Oncol. 2019 Nov;140:76-83. doi: 10.1016/j.radonc.2019.05.022. Epub 2019 Jun 8.

PMID:
31185327
18.

Comparison of 99mTc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy.

Hunt KN, Conners AL, Goetz MP, O'Connor MK, Suman V, Kalari K, Weinshilboum R, Wang L, Carter J, McLaughlin S, Aspitia AM, Gray R, Northfelt D, Boughey JC.

AJR Am J Roentgenol. 2019 Oct;213(4):932-943. doi: 10.2214/AJR.18.20628. Epub 2019 Jun 5.

PMID:
31166752
19.

Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.

Haffty BG, McCall LM, Ballman KV, Buchholz TA, Hunt KK, Boughey JC.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):174-182. doi: 10.1016/j.ijrobp.2019.04.038. Epub 2019 May 11.

PMID:
31085287
20.

Surgical Outcomes of Prepectoral Versus Subpectoral Implant-based Breast Reconstruction in Young Women.

Manrique OJ, Banuelos J, Abu-Ghname A, Nguyen MD, Tran NV, Martinez-Jorge J, Harless C, Sharaf B, Jakub JW, Degnim AC, Boughey JC, Jacobson SR.

Plast Reconstr Surg Glob Open. 2019 Mar 13;7(3):e2119. doi: 10.1097/GOX.0000000000002119. eCollection 2019 Mar.

21.

ASO Author Reflections: A Statistical Caution Regarding Missing Clinical Stage in the National Cancer Database.

Hoskin TL, Boughey JC.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):569-570. doi: 10.1245/s10434-019-07195-0. Epub 2019 Jan 31. No abstract available.

PMID:
30706230
22.

The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer.

Zhuang Y, Ly RC, Frazier CV, Yu J, Qin S, Fan XY, Goetz MP, Boughey JC, Weinshilboum R, Wang L.

Cancer Metab. 2019 Jan 24;7:1. doi: 10.1186/s40170-018-0193-4. eCollection 2019.

23.

Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ; I-SPY2 Investigators.

NPJ Breast Cancer. 2019 Jan 2;5:2. doi: 10.1038/s41523-018-0096-0. eCollection 2019.

24.

PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient.

Kalari KR, Sinnwell JP, Thompson KJ, Tang X, Carlson EE, Yu J, Vedell PT, Ingle JN, Weinshilboum RM, Boughey JC, Wang L, Goetz MP, Suman V.

JCO Clin Cancer Inform. 2018 Dec;2:1-11. doi: 10.1200/CCI.18.00012.

25.

Lessons Learned Regarding Missing Clinical Stage in the National Cancer Database.

Hoskin TL, Boughey JC, Day CN, Habermann EB.

Ann Surg Oncol. 2019 Mar;26(3):739-745. doi: 10.1245/s10434-018-07128-3. Epub 2019 Jan 4.

PMID:
30610561
26.

ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time-Highest Rates of Use Now in Triple-Negative and HER2+ Disease.

Murphy BL, Boughey JC.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):695-696. doi: 10.1245/s10434-018-7046-9. Epub 2018 Nov 21. No abstract available.

PMID:
30465221
27.

Intermediate and long-term outcomes of fibroadenoma excision in adolescent and young adult patients.

Javed A, Jenkins SM, Labow B, Boughey JC, Lemaine V, Neal L, Shah SS, Pruthi S.

Breast J. 2019 Jan;25(1):91-95. doi: 10.1111/tbj.13159. Epub 2018 Nov 16.

PMID:
30444280
28.

ASO Author Reflections: Rate of Axillary Lymph Node Dissection has Decreased in Patients Treated with Neoadjuvant Systemic Therapy.

Nguyen TT, Boughey JC.

Ann Surg Oncol. 2018 Dec;25(Suppl 3):693-694. doi: 10.1245/s10434-018-7045-x. Epub 2018 Nov 12. No abstract available.

PMID:
30421050
29.

A contemporary review of male breast cancer: current evidence and unanswered questions.

Leon-Ferre RA, Giridhar KV, Hieken TJ, Mutter RW, Couch FJ, Jimenez RE, Hawse JR, Boughey JC, Ruddy KJ.

Cancer Metastasis Rev. 2018 Dec;37(4):599-614. doi: 10.1007/s10555-018-9761-x. Review.

PMID:
30232577
30.

Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy.

Barron AU, Hoskin TL, Day CN, Hwang ES, Kuerer HM, Boughey JC.

JAMA Surg. 2018 Dec 1;153(12):1120-1126. doi: 10.1001/jamasurg.2018.2696.

31.

Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.

Buzdar AU, Suman VJ, Meric-Bernstam F, Leitch AM, Ellis MJ, Boughey JC, Unzeitig GW, Royce ME, Hunt KK.

JAMA Oncol. 2019 Jan 1;5(1):45-50. doi: 10.1001/jamaoncol.2018.3691.

32.

Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.

Kurmi K, Hitosugi S, Yu J, Boakye-Agyeman F, Wiese EK, Larson TR, Dai Q, Machida YJ, Lou Z, Wang L, Boughey JC, Kaufmann SH, Goetz MP, Karnitz LM, Hitosugi T.

Cell Metab. 2018 Dec 4;28(6):833-847.e8. doi: 10.1016/j.cmet.2018.08.008. Epub 2018 Aug 30.

33.

ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer.

Tu X, Kahila MM, Zhou Q, Yu J, Kalari KR, Wang L, Harmsen WS, Yuan J, Boughey JC, Goetz MP, Sarkaria JN, Lou Z, Mutter RW.

Mol Cancer Ther. 2018 Nov;17(11):2462-2472. doi: 10.1158/1535-7163.MCT-18-0470. Epub 2018 Aug 30.

34.

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.

Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ; and I-SPY 2 Investigators.

NPJ Breast Cancer. 2018 Aug 17;4:26. doi: 10.1038/s41523-018-0074-6. eCollection 2018. Review. Erratum in: NPJ Breast Cancer. 2019 Jan 2;5:2.

35.

The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB).

Fayanju OM, Ren Y, Thomas SM, Greenup RA, Plichta JK, Rosenberger LH, Tamirisa N, Force J, Boughey JC, Hyslop T, Hwang ES.

Ann Surg. 2018 Oct;268(4):591-601. doi: 10.1097/SLA.0000000000002953.

36.

HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data.

Baheti S, Tang X, O'Brien DR, Chia N, Roberts LR, Nelson H, Boughey JC, Wang L, Goetz MP, Kocher JA, Kalari KR.

BMC Bioinformatics. 2018 Jul 17;19(1):271. doi: 10.1186/s12859-018-2260-9.

37.

The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.

Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):2858-2866. doi: 10.1245/s10434-018-6583-6. Epub 2018 Jul 9.

38.

Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.

Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JC.

Support Care Cancer. 2019 Feb;27(2):495-503. doi: 10.1007/s00520-018-4334-7. Epub 2018 Jul 6.

PMID:
29980907
39.

Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.

Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC.

Ann Surg Oncol. 2018 Sep;25(9):2596-2602. doi: 10.1245/s10434-018-6637-9. Epub 2018 Jul 5.

PMID:
29978369
40.

Effect of Primary Breast Tumor Location on Axillary Nodal Positivity.

Desai AA, Hoskin TL, Day CN, Habermann EB, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):3011-3018. doi: 10.1245/s10434-018-6590-7. Epub 2018 Jul 2.

PMID:
29968027
41.

'Nudging' Surgeons and Patients to De-Escalation of Surgery for Breast Cancer.

Yao K, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):2777-2780. doi: 10.1245/s10434-018-6588-1. Epub 2018 Jul 2. No abstract available.

PMID:
29968025
42.

Predicting Non-sentinel Lymph Node Metastases in Patients with a Positive Sentinel Lymph Node After Neoadjuvant Chemotherapy.

Barron AU, Hoskin TL, Boughey JC.

Ann Surg Oncol. 2018 Oct;25(10):2867-2874. doi: 10.1245/s10434-018-6578-3. Epub 2018 Jun 28.

PMID:
29956095
43.

Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast.

Desai AA, Jimenez RE, Hoskin TL, Day CN, Boughey JC, Hieken TJ.

Ann Surg Oncol. 2018 Oct;25(10):3064-3068. doi: 10.1245/s10434-018-6591-6. Epub 2018 Jun 26.

PMID:
29947004
44.

Prepectoral Implant-Based Breast Reconstruction with Postmastectomy Radiation Therapy.

Elswick SM, Harless CA, Bishop SN, Schleck CD, Mandrekar J, Reusche RD, Mutter RW, Boughey JC, Jacobson SR, Lemaine V.

Plast Reconstr Surg. 2018 Jul;142(1):1-12. doi: 10.1097/PRS.0000000000004453.

PMID:
29878988
45.

Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes.

Murphy BL, Day CN, Hoskin TL, Habermann EB, Boughey JC.

Ann Surg Oncol. 2018 Aug;25(8):2241-2248. doi: 10.1245/s10434-018-6531-5. Epub 2018 May 21.

PMID:
29786125
46.

Ability of Intraoperative Pathologic Analysis of Ductal Carcinoma In Situ to Guide Selective Use of Sentinel Lymph Node Surgery.

Murphy BL, Gonzalez AB, Keeney MG, Chen B, Conners AL, Henrichsen TL, Degnim AC, Harmsen WS, Boughey JC, Hieken TJ, Habermann EB, Jakub JW.

Am Surg. 2018 Apr 1;84(4):537-542.

PMID:
29712602
47.

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.

Yu J, Qin B, Moyer AM, Nowsheen S, Liu T, Qin S, Zhuang Y, Liu D, Lu SW, Kalari KR, Visscher DW, Copland JA, McLaughlin SA, Moreno-Aspitia A, Northfelt DW, Gray RJ, Lou Z, Suman VJ, Weinshilboum R, Boughey JC, Goetz MP, Wang L.

J Clin Invest. 2018 Jun 1;128(6):2376-2388. doi: 10.1172/JCI97924. Epub 2018 Apr 30.

48.

Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.

West DC, Kocherginsky M, Tonsing-Carter EY, Dolcen DN, Hosfield DJ, Lastra RR, Sinnwell JP, Thompson KJ, Bowie KR, Harkless RV, Skor MN, Pierce CF, Styke SC, Kim CR, de Wet L, Greene GL, Boughey JC, Goetz MP, Kalari KR, Wang L, Fleming GF, Györffy B, Conzen SD.

Clin Cancer Res. 2018 Jul 15;24(14):3433-3446. doi: 10.1158/1078-0432.CCR-17-2793. Epub 2018 Apr 10.

49.

Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery.

Murphy BL, Boughey JC, Keeney MG, Glasgow AE, Racz JM, Keeney GL, Habermann EB.

Mayo Clin Proc. 2018 Apr;93(4):429-435. doi: 10.1016/j.mayocp.2017.11.023. Epub 2018 Feb 10.

PMID:
29439832
50.

Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).

Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JC.

AJR Am J Roentgenol. 2018 Mar;210(3):669-676. doi: 10.2214/AJR.17.18295. Epub 2018 Jan 30.

Supplemental Content

Loading ...
Support Center